Ana Babić

ORCID: 0000-0002-1096-0844 · 5 papers in corpus
preprint 2023
·doi:10.1158/1940-6207.c.6547454

AbstractMenstrual pain has been associated with increased ovarian cancer risk, presumably through increased inflammation, which is known to play a critical role in ovarian carcinogenesis. Analgesic medications are frequently used to treat m…

article 2021
Cancer prevention research (Philadelphia, Pa.) ·doi:10.1158/1940-6207.capr-21-0090

Abstract Menstrual pain has been associated with increased ovarian cancer risk, presumably through increased inflammation, which is known to play a critical role in ovarian carcinogenesis. Analgesic medications are frequently used to treat …

article 2017
International journal of cancer ·doi:10.1002/ijc.31010

Menstrual pain, a common gynecological condition, has been associated with increased risk of ovarian cancer in some, but not all studies. Furthermore, potential variations in the association between menstrual pain and ovarian cancer by hist…

article 2015
·doi:10.1158/1557-3265.ovcasymp14-as13

Abstract Background: CA125 is elevated in 80% of ovarian cancer cases and has proven utility in assessing response to therapy and prognosis. Unfortunately, CA125 is elevated in a variety of benign conditions and only in 50% of early stage o…

article 2014
Cancer causes & control : CCC ·doi:10.1007/s10552-014-0463-6

PurposeMenstrual pain is associated with increased production of inflammatory molecules, such as prostaglandins. Inflammation is involved in pathogenesis of several cancers, including ovarian cancer. In this study, we examined the associati…